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Original Article
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Abstract
Background: Air pollution and poor ambient air quality are significantly related to multiple health risks. One associated disease is
chronic obstructive pulmonary disease (COPD), a preventable disease with several contributing factors and one of the leading
causes of morbidity/mortality locally and globally. A potentially high-risk population are traffic enforcers who are constantly
exposed to air pollution. In the Philippines, the MMDA has the widest coverage in traffic management. The study determined the
risk of COPD among Metro Manila Development Authority (MMDA) traffic enforcers in relation to ambient air quality level, as
well as identified other factors that increase the risk of developing COPD.
Methods: Fifty-two MMDA traffic enforcers deployed in PM2.5 air quality sensor areas in Metro Manila from 2016 to 2018 were
recruited through stratified sampling. The International Primary Airways Guidelines (IPAG) questionnaire was utilized to measure
risk of COPD. Respiratory health and working history were obtained through questionnaires. Department of environment and
natural resources provided PM2.5 ambient air quality data which aided in the construction of the Exposure-Month Index. Ordinal
logistic regression was used to examine the association of PM2.5 together with the relevant factors and the risk of COPD.
Results: We found statistically significant associations between PM2.5 and COPD among high risk category [odds risk (OR): 1.24,
95% confidence interval (CI): 1.07e1.44]. Age (Moderate, OR: 1.16, 95% CI: 0.98e1.38 and High, OR: 10.06, 95% CI:
4.02e25.17) and chest pain (Moderate, OR: 68.65, 95% CI: 1.71e2.75  103) were potential risk factors, whereas body mass index
(BMI) (OR: 0.05, 95% CI: 0.01e0.53) exhibited protective effect.
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Conclusions: Exposure to PM2.5 was associated with an increased risk of COPD among high-risk category MMDA traffic enforcers. Age and chest pain were potential risk factors to risk of COPD, whereas BMI exhibited a potential protective effect. Results
of this study can be used for clinical management of high-risk populations, such that of MMDA traffic enforcers.
Copyright © 2021 Chinese Medical Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Chronic obstructive pulmonary disease; Traffic enforcers; Air pollution; Occupational risk; Philippines

Introduction
Globally, air pollution has negatively affected air
quality and has become a threat to public health. In
fact, 4.2 million deaths annually were estimated to be
due to ambient air pollution.1 Morbidity and mortality
from cardiovascular and respiratory causes, in particular, have been observed to be associated with particulate air pollution.2,3 Among the various criteria air
pollutants, particulate matter (PM) is found to be
responsible for the majority of associated health
risks.2,4 An increasing emphasis was thus placed on
PM with a size less than 2.5 microns in diameter
(PM2.5) because of its ability to reach distal regions of
the lung.5
One of the diseases associated with poor air quality
is chronic obstructive pulmonary disease (COPD),
which is a preventable yet commonly undiagnosed and
life-threatening respiratory condition.6 It is characterized by persistent limitation of airflow and enhanced
chronic inflammatory response in the airways to
noxious particles or gases.7 Mainstay symptoms of
COPD are chronic, progressive dyspnea, cough,
sputum, or mucus productiondthese usually become
apparent after 40e50 years of age.8
The primary cause of COPD remains to be exposure
to tobacco smoke. However, recent scientific developments revealed the substantial role of PM2.5 on
the exacerbation of COPD.8e13 Other modifiable risk
factors include obesity and occupational exposures to
organic and inorganic dusts, chemicals, fumes, and
irritants. Meanwhile, non-modifiable factors include
increasing age, male gender, lung development abnormalities, bronchial hyperreactivity, long-term
asthma, childhood respiratory infections, and family
history of respiratory diseases.7,14,15
In the Philippines, the Department of Health recognizes COPD as the seventh leading cause of mortality.16 In 2007, an estimated 14% of Metro Manila's
population alone reportedly had COPD.17 Several risk
factors are present in the countrydthe most significant
of which are air pollution (96%) in urban settings and
biomass exposure (87%) in rural settings.18 A

significant contributor to air pollution are motor vehiclesdthis is especially true in Metro Manila where
there is a 2.5 million annual average daily traffic.19 In
fact, the region's average PM2.5 level (30.44 mg/m3)
from 2016 to 2018 lies beyond the recommended
annual PM2.5 level (20 mg/m3) by the World Health
Organization.20 With considerably high ambient PM2.5
levels, outdoor occupations are mostly hazardous in
nature given the prolonged exposure.21
Traffic enforcers had the highest exposure, who
were found to have an increased risk of developing
respiratory and cardiac diseases.22e24 In Metro Manila,
the Metro Manila Development Authority (MMDA)
remains to be the agency with the widest coverage in
traffic management.19 On the job, MMDA traffic enforcers work on 8-hour shifts on weekdays. Given the
nature and scope of the work, the MMDA may then
adequately represent traffic enforcers with a high risk
of exposure to high levels air pollution in Metro
Manila.
In response to a growing need for evidence linking
air quality to health outcomes in the country, specifically among high risk groups, this study explored the
association between ambient air quality and risk of
COPD among MMDA traffic enforcers in Metro
Manila.
Methods
We utilized a cross-sectional study design in elucidating the risk of developing COPD due to ambient air
quality. The list of variables with their corresponding
units, definitions, type, and sources of information are
summarized in Table S1.
Ethical approval
Ethical clearance was obtained from the ASMPH
Ethical Research Board with Ethical Approval number:
SMPH 2019 Group 02. Permission to conduct the
study in the selected MMDA satellites was also coordinated with the main headquarters in Makati City and
each MMDA satellite head prior to each visit. Prior to
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assessment, all participants were briefed and given
informed written consent forms (see Supplementary
Document 3), detailing the purpose and methods of the
study and their rights as study participants. Gathered
data were kept confidential throughout the entire study,
in compliance with the Data Privacy Act of 2012.
Independent variable
For the independent variable, an Exposure-Month
Index (EMI) which is calculated as the average PM2.5
exposure of the participant in the month/s where s/he
was deployed. Since traffic enforcers are assigned to
different areas in varying time periods, EMI captures
the cumulative exposure of the traffic enforcers, which
is dependent on the length of time the subject stayed in
the location. The EMI was assessed with the aid of a
working history form (see Supplementary Document
1) and was computed as follows:
k
X
PM:2:5k
EMIy ¼
ð
Þ
duration
k
i¼1

whereby, k represents the work location; PM2.5 represents the PM2.5 concentration in the work location;
duration is the length of time the traffic officer was
assigned in that location. The summation of the duration weighted PM2.5 is the exposure index (EMIy ) for
traffic officer y.
PM 2.5 levels were obtained from air quality ground
monitoring data from the department of environment
and natural resources-air quality management section
(DENR-AQMS) measured via BAM (Thermos, Met 1)
and TEOM (Thermos) sensors from 2016 to 2018 (see
Table S2 for PM 2.5 Yearly Average).
Dependent variable
For the dependent variable, risk of COPD was
measured using the International Primary Airways
Guidelines (IPAG) risk score, which was later transformed into a categorical variable with three levels:
namely, low, moderate, and high risk. The IPAG
Questionnaire, highlighted in Appendix 1 of Sichletidis, Spyratos, Papaioannou et al,25 is the most widely
validated screening questionnaire aimed at determining
risk of COPD (sensitivity ¼ 64.5%; specificity
¼ 65.2%).26 This tool includes questions regarding
respiratory symptoms, smoking history, allergies, age,
and anthropometrics. There are a total of 38 points,
with a cut-off score of greater than 17 points as high
risk of COPD.27 The questionnaire was translated to
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Tagalog for comprehensibility and incorporated in the
Respiratory Health Questionnaire (see Supplementary
Document 2).
Study sites
The study was conducted in nine selected MMDA
satellite stations with an active PM2.5 air quality sensor
installed and monitored by the DENR-AQMS. Fig. 1
illustrates the coverage area of PM2.5 sensors within a
5-kilometer radius and the location of the different
MMDA satellites. Three-year PM2.5 levels in these
sites were obtained from DENR-AQMS and processed
with the assistance of environmental health experts at
the ASMPH Center for Research and Innovation
(ACRI), Environmental Health unit.
Study population
MMDA traffic enforcers satisfying any of the
following criteria were excluded from the study population: (1) were not currently assigned to the field, (2)
were assigned to the field for more than 6 months in an
area that does not have a PM 2.5 air quality sensor, (3)
were newly assigned to the field from January 2019
onwards, and (4) previously diagnosed with COPD
before January 2016. Study sample consisted of 52
MMDA traffic enforcers (prevalence ¼ 0.883%,
power ¼ 80, design effect ¼ 1, confidence
interval ¼ 95%) assigned to field jobs for at least 6
months.28
Data collection procedure
Pre-testing of questionnaires was done to three
participants in the EDSA-MMDA satellite for the
purpose of training the researchers and testing the data
collection instruments. During actual data collection, a
minimum of three researchers went per study site and
requested for available participants who were currently
not on duty. All data gathered were transcribed and
encrypted to ensure confidentiality and, afterwards,
will be permanently deleted once the study has
concluded.
Statistical analyses
Data obtained was encoded in Excel version 2016
(Microsoft, USA). We utilized an ordinal logistic
regression to assess association of the risk of COPD
and PM2.5, after adjusting for several covariates. A
bivariable analysis was utilized to examine the
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Fig. 1. Map of Metro Manila showing air quality sensors' area coverage (in circles) and selected MMDA satellites.

association of IPAG variable and the covariates.
Covariates which exhibited statistical significance were
then included to the full model in the multivariable
regression. The full model was then subjected to a
stepwise multivariable regression via backward elimination, whereby variables which did not show statistical significance in the full model were dropped oneby-one. The final model favored the inclusion of body
mass index (BMI), age, symptoms of chest pain and
PM2.5. The subsequent interpretations of the odds risk
(OR) for moderate and high categories are relative to
the low category, which is set as the base level of
comparison in the ordinal logistic regression. All statistical analyses were done using R Statistical Programming (R Development Core Team, USA).29
Results
In Table 1, we observed strong statistically significant association of the IPAG categories with age (High,

OR: 1.48, 95% CI: 1.05e2.07), pack years (Moderate,
OR:1.14, 95% CI: 0.03e50.94 and High, OR:1.20,
95% CI: 1.05e1.38), chest pain (Moderate, OR: 19.50,
95% CI: 6.97e54.57). Whereas, BMI (High, OR: 0.76,
95% CI: 0.57e1.02), years of service (High, OR: 1.11,
95% CI: 0.98e1.25), past respiratory disease (High,
OR: 6.17, 95% CI: 0.78e48.64) and PM2.5 (High, OR:
1.06, 95% CI: 0.99e1.13) exhibited a relatively moderate statistical significance. All statistically significant
variables exhibited a positive association with IPAG
categories, except for BMI, which indicated a possible
negative association.
Further multivariable, ordinal logistic regression
analysis favored a simpler model with the inclusion of
BMI (High, OR: 0.05, 95% CI: 0.01e0.53), age
(Moderate, OR: 1.16, 95% CI: 0.98e1.38 and High,
OR: 10.06, 95% CI: 4.02e25.17), chest pain (Moderate, OR: 68.65, 95% CI: 1.71e2.75  103) and PM2.5
(High, OR: 1.24, 95% CI: 1.07e1.44) as shown in
Table 2. While age and chest pain exhibited statistical
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Table 1
Bivariable, ordinal logistic regression results of International Primary Airways Guidelines categories with age.
Variables

Moderate

a

BMI
Agea
Current Smoker
Past Smoker
Years of Servicea
Pack Yearsa
Difficulty of Breathing
Sneezing
Colds
Atopy
Cough
Chest Paina
Shortness of Breath
Current Respiratory Disease
Past Respiratory Diseasea
Symptoms in family
Family history of respiratory disease
PM2.5a

High

OR (95% CI)

P values

OR (95% CI)

P values

0.90 (0.00e915)
1.09 (0.00e7.5  107)
0.31 (0.09e1.03)
0.51 (0.07e4.01)
1.09 (0.13e9.09)
1.14 (0.03e50.94)
1.55 (0.47e5.07)
0.87 (0.26e2.86)
1.55 (0.55e4.39)
e
0.83 (0.29e2.33)
19.50 (6.97e54.57)
0.39 (0.12e1.27)
3.90 (1.39e10.91)
4.62 (1.43e15.00)
2.56 (0.35e18.92)
1.35  104 (4.68  103e3.92  104)
1.03 (0.00e2.93  103)

0.36
0.14
0.31
0.51
0.12
0.03b
0.64
0.88
0.64
e
0.87
0.01b
0.40
0.30
0.13
0.31
0.82
0.32

0.76
1.48
1.04
1.54
1.11
1.20
2.07
1.16
0.78
2.31
1.03
4.88
1.29
4.87
6.17
5.11
0.32
1.06

0.07b
0.02b
0.97
0.74
0.10b
0.01b
0.46
0.88
0.83
0.50
0.98
0.23
0.80
0.23
0.08b
0.16
0.33
0.10b

(0.57e1.02)
(1.05e2.07)
(0.16e6.94)
(0.12e19.5)
(0.98e1.25)
(1.05e1.38)
(14.18e0.46)
(0.17e7.72)
(0.08e7.76)
(0.21e26.05)
(0.10e10.53)
(0.36e66.41)
(0.19e8.61)
(0.36e66.41)
(0.78e48.64)
(0.52e49.80)
(0.03e3.11)
(0.99e1.13)

BMI: Body Mass Index; OR: Odds Ratio; 95% CI: 95% Confidence Interval; PM2.5: particulate matter with a size of 2.5 microns or less in diameter.
Reference level of COPD risk is low.
a
Variables which were included in the full model of the subsequent multivariable, multinomial analysis.
b
P value  0.10 indicate statistical significance.

significance in the high and moderate categories,
respectively, results should be interpreted with caution
due to the substantially wide confidence intervals. We
observe a consistent statistically significant and negative association of BMI with IPAG category.
Discussion
In this study, we examined the effects of ambient air
pollution on the risk of COPD and observed statistically significant association between PM2.5 exposure
and the risk of COPD among MMDA traffic enforcers,
after adjusting for relevant covariates. Several risk and
protective factors, aside from PM2.5, were also
observed.

PM2.5 and COPD
We observed statistically significant association
between PM2.5 exposure and the risk of COPD. A unit
increase in PM2.5 exposure was associated with a statistically significant OR in high-risk category (OR:
1.24, 95% CI: 1.07e1.44) relative to the low-risk
category, in Table 2. Among high risk populations,
such as traffic enforcers, studies have indicated a
decline in the workers’ lung function due to trafficgenerated PM2.5.30 In India, taxi motorcyclists were
observed to have substantial risk in developing
restrictive syndrome, a form of impairment in the
pulmonary function.31 In Zagreb and Croatia, Zuskin
et al32 noted the higher risks in developing respiratory

Table 2
Multivariate, ordinal logistic regression results of final model.
Variable

Moderate

High

OR (95% CI)

P values

OR (95% CI)

P values

BMI
Age
Chest Pain
PM2.5

0.87 (0.65e1.18)
1.16 (0.98e1.38)
68.65 (1.71e2.75  103)
1.01 (0.94e1.08)

0.37
0.09a
0.03a
0.87

0.05 (0.01e0.53)
10.06 (4.02e25.17)
0.12 (6.33  107 e 2.28  104)
1.24 (1.07e1.44)

0.01a
<0.001a
0.73
0.01a

BMI: Body Mass Index; OR: Odds Ratio; 95% CI: 95% Confidence Interval; PM2.5: particulate matter with a size of 2.5 microns or less in diameter.
a
P value  0.10 indicate statistical significance.
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symptoms for bus drivers and mechanics. Epidemiological studies have demonstrated an association between short-term ambient PM2.5 exposure and lung
function decline. Short-term exposure to ambient air
pollutants are said to result in oxidative stress and
pulmonary and systemic inflammatory responses such
as reduction in the ciliary activity in the airways and
acute decrease of pulmonary function.9 Schikowski
et al9 argued that if repeated acute exacerbations of
COPD were considered a factor in the development of
COPD, then the causal role of air pollution in aggravation of COPD is substantial. That being said, the
effect of long-term exposure to PM2.5 is slowly but
considerably being investigated and has been additionally associated with increased morbidity and mortality of COPD. A recent longitudinal cohort study by
Guo et al33 found that PM2.5 was consistently associated with reduction in lung function with respect to
four parametersdnamely FEV1, FVC, MMEF, and
FEV1/FVC ratiodas well as increased risk of COPD
development. Prolonged and chronic exposure may
potentially induce pulmonary inflammation, decrease
lung function, and cause emphysematous changes.34
Likewise, this study supports the reported specificity
and sensitivity of IPAG Questionnaire as the most
widely validated screening questionnaire for COPD.
COPD risk factors: age and chest pain
Age was positively associated with the risk of
COPD in the high-risk category (OR: 10.06, 95% CI:
4.02e25.17) compared to the low-risk category; Table
2. The prevalence and manifestations of COPD increases with age for both men and women throughout
most of the lifespan, especially among those above
40e50 years old.35 Since COPD is a progressive lung
disease, symptoms worsen over time and often do not
appear until there is significant lung damage. Aside
from age, we also observed that symptom of chest
pain was associated with statistically significant, yet
with highly uncertain effects estimates. HajGhanbari
et al36 noted that the hyper-expanded and relatively
rigid chest wall, which affects the thoracic articulations in a hyper extended position, may contribute to
thoracic pain experienced by people with COPD.
Whereas, Bordoni et al37 posits the role of costal
muscles, which face an alteration of their physiologic
length (shortening or lengthening) caused by the
change of costal biomechanics, influenced in turn by
lung movements. However, due to the relatively uncertain effects estimate of chest pain, further studies
are warranted.

COPD protective factor: BMI
Aside from risk factors, we observed statistically
significant protective factor of BMI on the risk of
COPD. A unit increase in BMI was associated with a
decrease in the risk for COPD among high-risk category (OR: 0.05, 95%CI: 0.01e0.53). Galesanu et al38
observed similar findings noting that overweight/obese
patients had better lung function and a larger midthigh
muscle cross-sectional area obtained using computed
tomography (MTCSACT) than those with normal BMI
as well as significantly higher peak work rate than
patients with normal BMI. A likely mechanism proposed by Divo et al39 posits the role of adipose tissue
plays a modulating role in disease expression in the
two (normal and obese) groups as the disease begins
and progresses. Sun et al,40 on the other hand, postulates a possible reverse-causation, where increased
COPD disease activity or severity leads to weight loss
and cachexia. We invite the readers to read the systematic review by Sun et al40 for a detailed discussion
regarding the inverse association of BMI and COPD.
The study recognizes the following limitations.
First, this study only included ambient air quality data
from designated PM2.5 sensors of the DENR-AQMS.
Indoor air pollution was not quantified. Other gaseous
pollutants (e.g. nitric oxide) aside from PM2.5 were not
taken into account. Second, the developed ExposureMonth Index incorporates only the three most recent
years of the participants' working history. Additionally,
with a cross-sectional study design, exposure and
outcomes were assessed simultaneously, thereby only
capturing a snapshot of the participants’ health. Third,
although the IPAG Questionnaire is a widely used
screening tool, it does not account other risk factors of
COPD. Additional information regarding respiratory
health as well as candidate risk factors is encouraged.
Fourth, because of the number of associated risk factors, a larger sample size may be more appropriate for
future studies. Fifth, this study does not aim to clinically diagnose COPD. The clinical diagnosis of COPD
requires a more extensive history taking and physical
examination by a certified and experienced medical
practitioner. Other subsequent tests may also aid in the
accurate diagnosis of COPD, such as a post-bronchodilator spirometry assessment, arterial blood gas, and
chest radiograph, all of which our study did not
include.
In conclusion, exposure to PM2.5 was associated
with an increased risk of COPD among high-risk
category MMDA traffic enforcers. While age and
symptom of chest pain may potentially pose a risk in
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developing COPD, caution should be exercised due to
substantial uncertainty in the effect estimates. On the
other hand, BMI exhibited a potential protective effect
on the risk of COPD. Results of this study can be used
for clinical management of high-risk populations, such
that of MMDA traffic enforcers.
Conflicts of interest
None.
Appendix A. Supplementary data
Supplementary data to this article can be found
online at https://doi.org/10.1016/j.cdtm.2021.01.002.
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